Biotech Archives - Page 30 of 795

2 minute read

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 11:02 AM

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

ALPMF

1 minute read

‘Amid Acquisition Speculation, Cytokinetics CEO Stresses Company Can Launch Heart Drug On Its Own’ – STAT News

By Benzinga Newsdesk

May 17, 10:50 AM

https://www.statnews.com/2024/05/17/cytokinetics-robert-blum-stat-breakthrough-summit-west/ As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart

CYTK

1 minute read

GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale

By Vandana Singh

May 17, 10:45 AM

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.

GSK

1 minute read

FDA Gives Accelerated Approval To Amgen’s Drug For Small Cell Lung Cancer Patients

By Vandana Singh

May 17, 10:01 AM

FDA approves Amgen's Imdelltra for treating ES-SCLC, based on response rate and DoR in clinical studies. Approval may depend on further trials.

AMGN

4 minute read

Biden’s Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance

By Nicolas Jose Rodriguez

May 16, 4:41 PM

In an exclusive interview with Benzinga Cannabis, Aaron Bloom, an attorney and CEO of DocMJ, a multistate cannabis clinic, delved into the legal steps for rescheduling cannabis to Schedule III in the

TCNNF

1 minute read

Myriad Genetics Study Published In JCO Precision Oncology Shows Co’s Prolaris Test Can Predict Benefit Of Hormone Therapy Treatment In Men With Localized Prostate Cancer

By Benzinga Newsdesk

May 16, 4:30 PM

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN),

MYGN

1 minute read

CareDx Presents Findings from The SHORE Study, HeartCare Outperforms dd-cfDNA Alone In Identifying Rejection And Patients Experienced Fewer Biopsies

By Benzinga Newsdesk

May 16, 4:24 PM

HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular RejectionCardiologists Performed the Fewest Biopsies After Dual Negative HeartCare Results Compared to Single or Dual Positive

CDNA

1 minute read

Evoke Pharma Presents Additional GIMOTI Healthcare Utilization Data Focused On Gastroparesis Care Insights In Women At DDW 2024 Conference

By Benzinga Newsdesk

May 16, 4:22 PM

Evoke Pharma, Inc.(NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that

EVOK

1 minute read

Inventiva Receives Recommendation From The 4th Scheduled Data Monitoring Committee Meeting Of The NATiV3 Phase III Clinical Trial With Lanifibranor In Patients With MASH/NASH

By Benzinga Newsdesk

May 16, 4:02 PM

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review

IVA

2 minute read

Attention Biotech Investors – Stocks To Watch

By Vandana Singh

May 16, 2:21 PM

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences, and Corbus Pharmaceuticals with key 2024 data readouts and trials.

AGIO